Copyright Reports & Markets. All rights reserved.

Global Anal and Colorectal Cancer Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Anal and Colorectal Cancer Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Anal and Colorectal Cancer Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Surgery
    • 1.4.3 Radiation therapy
    • 1.4.4 Colorectal cancer chemotherapy
    • 1.4.5 Targeted therapy
    • 1.4.6 Immunotherapy
  • 1.5 Market by Application
    • 1.5.1 Global Anal and Colorectal Cancer Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Ambulatory surgery centers
    • 1.5.4 Cancer research centers
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Anal and Colorectal Cancer Market Perspective (2015-2026)
  • 2.2 Global Anal and Colorectal Cancer Growth Trends by Regions
    • 2.2.1 Anal and Colorectal Cancer Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Anal and Colorectal Cancer Historic Market Share by Regions (2015-2020)
    • 2.2.3 Anal and Colorectal Cancer Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Anal and Colorectal Cancer Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Anal and Colorectal Cancer Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Anal and Colorectal Cancer Players by Market Size
    • 3.1.1 Global Top Anal and Colorectal Cancer Players by Revenue (2015-2020)
    • 3.1.2 Global Anal and Colorectal Cancer Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Anal and Colorectal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Anal and Colorectal Cancer Market Concentration Ratio
    • 3.2.1 Global Anal and Colorectal Cancer Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Anal and Colorectal Cancer Revenue in 2019
  • 3.3 Anal and Colorectal Cancer Key Players Head office and Area Served
  • 3.4 Key Players Anal and Colorectal Cancer Product Solution and Service
  • 3.5 Date of Enter into Anal and Colorectal Cancer Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Anal and Colorectal Cancer Historic Market Size by Type (2015-2020)
  • 4.2 Global Anal and Colorectal Cancer Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Anal and Colorectal Cancer Market Size by Application (2015-2020)
  • 5.2 Global Anal and Colorectal Cancer Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Anal and Colorectal Cancer Market Size (2015-2020)
  • 6.2 Anal and Colorectal Cancer Key Players in North America (2019-2020)
  • 6.3 North America Anal and Colorectal Cancer Market Size by Type (2015-2020)
  • 6.4 North America Anal and Colorectal Cancer Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Anal and Colorectal Cancer Market Size (2015-2020)
  • 7.2 Anal and Colorectal Cancer Key Players in Europe (2019-2020)
  • 7.3 Europe Anal and Colorectal Cancer Market Size by Type (2015-2020)
  • 7.4 Europe Anal and Colorectal Cancer Market Size by Application (2015-2020)

8 China

  • 8.1 China Anal and Colorectal Cancer Market Size (2015-2020)
  • 8.2 Anal and Colorectal Cancer Key Players in China (2019-2020)
  • 8.3 China Anal and Colorectal Cancer Market Size by Type (2015-2020)
  • 8.4 China Anal and Colorectal Cancer Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Anal and Colorectal Cancer Market Size (2015-2020)
  • 9.2 Anal and Colorectal Cancer Key Players in Japan (2019-2020)
  • 9.3 Japan Anal and Colorectal Cancer Market Size by Type (2015-2020)
  • 9.4 Japan Anal and Colorectal Cancer Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Anal and Colorectal Cancer Market Size (2015-2020)
  • 10.2 Anal and Colorectal Cancer Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Anal and Colorectal Cancer Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Anal and Colorectal Cancer Market Size by Application (2015-2020)

11 India

  • 11.1 India Anal and Colorectal Cancer Market Size (2015-2020)
  • 11.2 Anal and Colorectal Cancer Key Players in India (2019-2020)
  • 11.3 India Anal and Colorectal Cancer Market Size by Type (2015-2020)
  • 11.4 India Anal and Colorectal Cancer Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Anal and Colorectal Cancer Market Size (2015-2020)
  • 12.2 Anal and Colorectal Cancer Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Anal and Colorectal Cancer Market Size by Type (2015-2020)
  • 12.4 Central & South America Anal and Colorectal Cancer Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott Diagnostics
    • 13.1.1 Abbott Diagnostics Company Details
    • 13.1.2 Abbott Diagnostics Business Overview
    • 13.1.3 Abbott Diagnostics Anal and Colorectal Cancer Introduction
    • 13.1.4 Abbott Diagnostics Revenue in Anal and Colorectal Cancer Business (2015-2020))
    • 13.1.5 Abbott Diagnostics Recent Development
  • 13.2 Advaxis
    • 13.2.1 Advaxis Company Details
    • 13.2.2 Advaxis Business Overview
    • 13.2.3 Advaxis Anal and Colorectal Cancer Introduction
    • 13.2.4 Advaxis Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 13.2.5 Advaxis Recent Development
  • 13.3 Abbott
    • 13.3.1 Abbott Company Details
    • 13.3.2 Abbott Business Overview
    • 13.3.3 Abbott Anal and Colorectal Cancer Introduction
    • 13.3.4 Abbott Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 13.3.5 Abbott Recent Development
  • 13.4 Amgen
    • 13.4.1 Amgen Company Details
    • 13.4.2 Amgen Business Overview
    • 13.4.3 Amgen Anal and Colorectal Cancer Introduction
    • 13.4.4 Amgen Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 13.4.5 Amgen Recent Development
  • 13.5 Atara Biotherapeutics
    • 13.5.1 Atara Biotherapeutics Company Details
    • 13.5.2 Atara Biotherapeutics Business Overview
    • 13.5.3 Atara Biotherapeutics Anal and Colorectal Cancer Introduction
    • 13.5.4 Atara Biotherapeutics Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 13.5.5 Atara Biotherapeutics Recent Development
  • 13.6 Bayer
    • 13.6.1 Bayer Company Details
    • 13.6.2 Bayer Business Overview
    • 13.6.3 Bayer Anal and Colorectal Cancer Introduction
    • 13.6.4 Bayer Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 13.6.5 Bayer Recent Development
  • 13.7 Metabiomics
    • 13.7.1 Metabiomics Company Details
    • 13.7.2 Metabiomics Business Overview
    • 13.7.3 Metabiomics Anal and Colorectal Cancer Introduction
    • 13.7.4 Metabiomics Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 13.7.5 Metabiomics Recent Development
  • 13.8 Beckman Coulter
    • 13.8.1 Beckman Coulter Company Details
    • 13.8.2 Beckman Coulter Business Overview
    • 13.8.3 Beckman Coulter Anal and Colorectal Cancer Introduction
    • 13.8.4 Beckman Coulter Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 13.8.5 Beckman Coulter Recent Development
  • 13.9 BeiGene
    • 13.9.1 BeiGene Company Details
    • 13.9.2 BeiGene Business Overview
    • 13.9.3 BeiGene Anal and Colorectal Cancer Introduction
    • 13.9.4 BeiGene Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 13.9.5 BeiGene Recent Development
  • 13.10 Boehringer Ingelheim
    • 13.10.1 Boehringer Ingelheim Company Details
    • 13.10.2 Boehringer Ingelheim Business Overview
    • 13.10.3 Boehringer Ingelheim Anal and Colorectal Cancer Introduction
    • 13.10.4 Boehringer Ingelheim Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 13.10.5 Boehringer Ingelheim Recent Development
  • 13.11 Clinical Genomics
    • 10.11.1 Clinical Genomics Company Details
    • 10.11.2 Clinical Genomics Business Overview
    • 10.11.3 Clinical Genomics Anal and Colorectal Cancer Introduction
    • 10.11.4 Clinical Genomics Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 10.11.5 Clinical Genomics Recent Development
  • 13.12 EDP Biotech
    • 10.12.1 EDP Biotech Company Details
    • 10.12.2 EDP Biotech Business Overview
    • 10.12.3 EDP Biotech Anal and Colorectal Cancer Introduction
    • 10.12.4 EDP Biotech Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 10.12.5 EDP Biotech Recent Development
  • 13.13 Eli Lilly
    • 10.13.1 Eli Lilly Company Details
    • 10.13.2 Eli Lilly Business Overview
    • 10.13.3 Eli Lilly Anal and Colorectal Cancer Introduction
    • 10.13.4 Eli Lilly Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 10.13.5 Eli Lilly Recent Development
  • 13.14 Epigenomics
    • 10.14.1 Epigenomics Company Details
    • 10.14.2 Epigenomics Business Overview
    • 10.14.3 Epigenomics Anal and Colorectal Cancer Introduction
    • 10.14.4 Epigenomics Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 10.14.5 Epigenomics Recent Development
  • 13.15 Exact Sciences
    • 10.15.1 Exact Sciences Company Details
    • 10.15.2 Exact Sciences Business Overview
    • 10.15.3 Exact Sciences Anal and Colorectal Cancer Introduction
    • 10.15.4 Exact Sciences Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 10.15.5 Exact Sciences Recent Development
  • 13.16 Genomictree
    • 10.16.1 Genomictree Company Details
    • 10.16.2 Genomictree Business Overview
    • 10.16.3 Genomictree Anal and Colorectal Cancer Introduction
    • 10.16.4 Genomictree Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 10.16.5 Genomictree Recent Development
  • 13.17 Immunovaccine
    • 10.17.1 Immunovaccine Company Details
    • 10.17.2 Immunovaccine Business Overview
    • 10.17.3 Immunovaccine Anal and Colorectal Cancer Introduction
    • 10.17.4 Immunovaccine Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 10.17.5 Immunovaccine Recent Development
  • 13.18 ISA Pharmaceuticals
    • 10.18.1 ISA Pharmaceuticals Company Details
    • 10.18.2 ISA Pharmaceuticals Business Overview
    • 10.18.3 ISA Pharmaceuticals Anal and Colorectal Cancer Introduction
    • 10.18.4 ISA Pharmaceuticals Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 10.18.5 ISA Pharmaceuticals Recent Development
  • 13.19 Merck
    • 10.19.1 Merck Company Details
    • 10.19.2 Merck Business Overview
    • 10.19.3 Merck Anal and Colorectal Cancer Introduction
    • 10.19.4 Merck Revenue in Anal and Colorectal Cancer Business (2015-2020)
    • 10.19.5 Merck Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Anal and Colorectal Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anal and Colorectal Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Abbott Diagnostics
    Advaxis
    Abbott
    Amgen
    Atara Biotherapeutics
    Bayer
    Metabiomics
    Beckman Coulter
    BeiGene
    Boehringer Ingelheim
    Clinical Genomics
    EDP Biotech
    Eli Lilly
    Epigenomics
    Exact Sciences
    Genomictree
    Immunovaccine
    ISA Pharmaceuticals
    Merck

    Market segment by Type, the product can be split into
    Surgery
    Radiation therapy
    Colorectal cancer chemotherapy
    Targeted therapy
    Immunotherapy
    Market segment by Application, split into
    Hospitals
    Ambulatory surgery centers
    Cancer research centers

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now